申请人:Akagera Medicines, Inc.
公开号:US20220162521A1
公开(公告)日:2022-05-26
The present disclosure provides compounds useful as ionizable cationic lipids. The ionizable cationic lipids are useful for preparing lipid nanoparticles for the delivery of therapeutic nucleic acids to cells. Cationic ionizable lipids were engineered with improved stability to oxidative degradation while in storage.
本公开提供了可用作离子化阳离子脂质体的化合物。这些离子化阳离子脂质体可用于制备脂质纳米粒子,以将治疗性核酸传递到细胞中。改进了阳离子离子化脂质体的稳定性,以防止在储存过程中发生氧化降解。